Investors are incredibly excited about Canopy Growth Corporation. But we’re now looking at a situation where the stock has increased quite aggressively thanks mostly to the belief that the future is bright. And there are still many investors sitting on the sidelines wondering if they should consider this company.
Tag Archives: Mettrum Health Corp.
Why 2017 Is the Year to Invest in Marijuana
On the face of it, 2017 may be the year to jump into the marijuana market to get a piece of what looks to be promising growth over the next few years.
Canopy Growth and Mettrum Announce Respective Shareholder Approvals of the Plan of Arrangement
SMITH FALLS, Ontario, Jan. 27, 2017 /Weed Wire/ — Canopy Growth Corporation (“Canopy Growth”) (TSX:CGC) and Mettrum Health Corp. (“Mettrum”) (TSX VENTURE:MT) (together, the “Companies”) are pleased to announce the successful results of the Special Meetings of Shareholders of Canopy Growth and Mettrum, held in Smiths Falls, Ontario and Toronto, Ontario, respectively, to approve Canopy Growth’s acquisition of Mettrum by way of a plan of arrangement (the “Arrangement”), as previously announced by the Companies on December 1, 2016.
Canopy Growth Corp.: When Should You Buy This Stock?
Canopy Growth Corp. (TSX:CGC) has been on a wild ride in recent months, and investors who think the name has long-term potential are trying to decided when they should buy.
Marijuana Shares Rise With Release of Recreational Use Recommendations
Pot stocks got a lift Tuesday following the issue of a task force report with recommendations on recreational pot sales.
Canopy Growth: This $430-Million Deal Is Huge for Pot Stocks
Is Canopy Growth about to become a mega marijuana stock company?
Mettrum to Sell Non-Core Subsidiary for $7 Million and Enters Three Year Product Supply Agreement
TORONTO, Ontario, Sept. 20, 2016 /Weed Wire/ — Mettrum Health Corp. (“Mettrum” or the “Company”) (TSX VENTURE:MT) is pleased to announce that it has entered into an agreement with Cannabis Care Canada Inc. (“CCC”) to sell to CCC its wholly-owned subsidiary Mettrum (Bennett North) Ltd. Mettrum Health Corp. announced that it has entered into an agreement with Cannabis Care Canada Inc. to sell to CCC its wholly-owned subsidiary Mettrum (Bennett North) Ltd.
Mettrum Health Corp. Closes $15 Million Bought Deal Offering of Common Shares
TORONTO, Ontario, Aug. 26, 2016 /Weed Wire/ — Mettrum Health Corp. (“Mettrum” or the “Company”), (TSX VENTURE:MT), a vertically integrated provider of cannabis products, is pleased to announce that it has completed its previously announced bought deal offering of 5,661,000 common shares of the Company (the “Shares”), at a price of $2.65 per Share for aggregate gross proceeds of $15,001,650 (the “Offering”).
Mettrum Announces $10 Million Bought Deal Financing
TORONTO, Ontario, Aug. 8, 2016 /Weed Wire/ — Mettrum Health Corp. (“Mettrum” or the “Company”) (TSX VENTURE:MT), a vertically integrated provider of cannabis products, is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Cormark Securities Inc.